Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Sleep-Oriented Intervention for Suicidal Behaviors

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Stanford University
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01770587
First received: January 14, 2013
Last updated: November 21, 2014
Last verified: November 2014
  Purpose
An open-label trial to investigate the use of a behavioral insomnia treatment for suicidal ideation.

Condition Intervention
Insomnia
Suicidal Ideation
Behavioral: Behavioral Insomnia Treatment

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Sleep-Oriented Intervention for Suicidal Behaviors

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Suicidal Ideation [ Time Frame: Change from Baseline in Suicidal Ideation at 8 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: May 2013
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Behavioral Insomnia Treatment
Behavioral Insomnia Treatment
Behavioral: Behavioral Insomnia Treatment

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • Age 18 or older
  • Clinically significant sleep disturbances
  • Diagnosis of depression
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01770587

Contacts
Contact: Naomi Iwata, MS niwata@stanford.edu

Locations
United States, California
Stanford University, Dept. of Psychiatry and Behavioral Sciences Recruiting
Stanford, California, United States, 94304
Principal Investigator: Rebecca A Bernert, PhD         
Sponsors and Collaborators
Stanford University
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Rebecca A Bernert, PhD Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01770587     History of Changes
Other Study ID Numbers: 22393  K23MH093490 
Study First Received: January 14, 2013
Last Updated: November 21, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Insomnia
Sleep
Behavioral Medicine
Suicide
Suicidal Ideation

Additional relevant MeSH terms:
Sleep Initiation and Maintenance Disorders
Suicidal Ideation
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders
Suicide
Self-Injurious Behavior
Behavioral Symptoms

ClinicalTrials.gov processed this record on September 30, 2016